Current status of monosodium glutamate.
D000109:Acetylcholine / Q000009:adverse effects; D000818:Animals; D001224:Aspartic Acid / Q000009:adverse effects; D002490:Central Nervous System / Q000187:drug effects; D002802:Cholinesterases / Q000097:blood; D003677:Deficiency Diseases / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005503:Food Additives; D005971:Glutamates / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000378:metabolism; D012964:Sodium
D005503:Food Additives; D005971:Glutamates; D001224:Aspartic Acid; D012964:Sodium; D002802:Cholinesterases; D000109:Acetylcholine